Published in J Comp Neurol on August 15, 1990
Mechanisms of action of CCK to activate central vagal afferent terminals. Peptides (2008) 0.92
Systemic cholecystokinin amplifies vago-vagal reflex responses recorded in vagal motor neurones. J Physiol (2011) 0.81
Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum. J Neural Transm (Vienna) (2010) 0.76
CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24
A simple, rapid method for the purification of poly A+ RNA. Biotechniques (1988) 3.22
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology (1996) 2.01
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol (2001) 1.85
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J Biol Chem (2000) 1.70
A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61
Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet (1984) 1.57
Cord blood mononuclear cell cytokine responses in relation to maternal house dust mite allergen exposure. Clin Exp Allergy (2002) 1.51
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med (2001) 1.48
Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A (1986) 1.46
Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J Exp Med (1983) 1.27
Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. Eur J Immunol (1999) 1.25
Automobile emissions are statistically gamma distributed. Environ Sci Technol (1994) 1.24
Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology (1996) 1.19
Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res (1997) 1.19
False detection of negative-strand hepatitis C virus RNA. Lancet (1994) 1.18
Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J Immunol (1997) 1.17
Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J Virol (1986) 1.16
Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J Immunol (1999) 1.15
Different CD40-mediated signaling events require distinct CD40 structural features. J Immunol (1996) 1.15
On-road vehicle emissions: regulations, costs, and benefits. Science (1995) 1.11
Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. J Immunol (1984) 1.11
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev (2000) 1.11
Oxygen binding constants for human hemoglobin tetramers. Biochemistry (1987) 1.09
The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J Immunol (1999) 1.08
Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation (1993) 1.08
Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J Immunol (2000) 1.05
Cytokine profiles in spontaneously regressing basal cell carcinomas. Br J Dermatol (2000) 1.05
Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study. Brain Res (1980) 1.04
Role of interferon in human natural killer activity against target cells infected with HSV-1. J Immunol (1983) 1.04
Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology (1994) 1.02
Physiological and anatomical studies of the interactions between Purkinje cells and basket cells in the cat's cerebellar cortex: evidence for a unitary relationship. J Neurosci (1989) 1.01
Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01
Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection. Transplant Proc (2009) 1.00
Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation (1995) 1.00
T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. J Invest Dermatol (1997) 0.99
CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J Immunol (1996) 0.99
Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology (1997) 0.98
Morphological and physiological properties of neostriatal neurons: an intracellular horseradish peroxidase study in the rat. Neuroscience (1982) 0.97
Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation (1999) 0.97
The distribution and origin of serotonin immunoreactivity in the rat cerebellum. Brain Res (1985) 0.96
Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol (1999) 0.95
Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation (2000) 0.95
H-2 control of expression of an idiotype shared by normal B cells and a B-cell lymphoma. Immunogenetics (1985) 0.94
The use of electron microscopic immunocytochemistry with silver-enhanced 1.4-nm gold particles to localize GAD in the cerebellar nuclei. J Histochem Cytochem (1995) 0.93
Morphological and electrophysiological characteristics of projection neurons in the nucleus interpositus of the cat cerebellum. J Comp Neurol (1978) 0.92
Allele non-amplification: a source of confusion in linkage studies employing microsatellite polymorphisms. Hum Mol Genet (1993) 0.91
IR long-path photometry: a remote sensing tool for automobile emissions. Anal Chem (1989) 0.90
Differential structure-function requirements of the transmembranal domain of the B cell antigen receptor. J Exp Med (1992) 0.89
Electrophysiological and horseradish peroxidase studies of precerebellar afferents to the nucleus interpositus anterior. II. Mossy fiber system. Brain Res (1977) 0.89
Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon. Br J Pharmacol (2009) 0.88
Signaling through MHC class II molecules blocks CD95-induced apoptosis. J Immunol (2001) 0.88
Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance. Transplantation (1998) 0.88
High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein. Proc Natl Acad Sci U S A (1988) 0.87
Intracellular staining of Purkinje cells and their axons with horseradish peroxidase. Brain Res (1976) 0.87
Enhancement of human natural killer cells by interferon requires RNA and protein synthesis. Clin Immunol Immunopathol (1982) 0.87
Expression of HLA antigens on renal tubular cells in culture. I. Evidence that mixed lymphocyte culture supernatants and gamma interferon increase both class I and class II HLA antigens. Transplantation (1986) 0.86
Cutting edge: a novel mechanism for rescue of B cells from CD95/Fas-mediated apoptosis. J Immunol (1999) 0.86
Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation (1994) 0.85
Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation (1999) 0.85
Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology (1993) 0.85
Electrophysiological and horseradish peroxidase studies of precerebellar afferents to the nucleus interpositus anterior. I. Climbing fiber system. Brain Res (1977) 0.85
Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling. J Immunol (1993) 0.85
A horseradish peroxidase study of the cortico-olivary projection in the cat. Brain Res (1976) 0.84
Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. J Immunol (2001) 0.83
Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation (1996) 0.83
Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance. Am J Transplant (2013) 0.83
Induction of HLA-DR antigens on cultured human kidney cells. Transplant Proc (1986) 0.82
An HRP and autoradiographic study of the projection from the cerebellar cortex to the nucleus interpositus anterior and nucleus interpositus posterior of the cat. J Comp Neurol (1979) 0.81
The cytoplasmic and transmembrane domains of MHC class II beta chains deliver distinct signals required for MHC class II-mediated B cell activation. Immunity (1995) 0.81
Stimulation of the inferior olivary complex alters the distribution of the type 1 corticotropin releasing factor receptor in the adult rat cerebellar cortex. Neuroscience (2008) 0.81
A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology (1990) 0.81
An enzyme-immunoassay for myoglobin in human serum and urine. Method development, normal values and application to acute myocardial infarction. Pathology (1979) 0.80
Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells. Kidney Int (1991) 0.80
Corticotropin releasing factor induces proliferation of cerebellar astrocytes. J Neurosci Res (2000) 0.80
Time course of upregulation of fibrogenic growth factors and cellular infiltration in a rodent model of chronic renal allograft rejection. Transpl Immunol (2002) 0.79
Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res (1997) 0.79
Role of the interleukin 2 receptor in differentiation of a clone of Ly-1+ B cells. J Immunol (1987) 0.79
Cell bodies of origin of serotonin-immunoreactive afferents to the inferior olivary complex of the rat. Brain Res (1986) 0.79
Frequency-dependent expression of corticotropin releasing factor in the rat's cerebellum. Neuroscience (2003) 0.79
The physiological effects of serotonin are mediated by the 5HT1A receptor in the cat's cerebellar cortex. Brain Res (1992) 0.79
The synaptic features of horseradish peroxidase-labelled recurrent collaterals in the ganglionic plexus of the cat cerebellar cortex. J Neurocytol (1982) 0.79
Altered zonal expression of the CD26 antigen (dipeptidyl peptidase IV) in human cirrhotic liver. Hepatology (1992) 0.79
An analysis of the morphology and cytology of HRP labeled Purkinje cells. Brain Res Bull (1981) 0.79
An analysis of HRP-filled basket cell axons in the cat's cerebellum. II. Axonal distribution. Anat Embryol (Berl) (1993) 0.79
Distribution of corticotropin-releasing factor in the cerebellum and precerebellar nuclei of the opossum: a study utilizing immunohistochemistry, in situ hybridization histochemistry, and receptor autoradiography. J Comp Neurol (1989) 0.79
Topographical organization in the origin of serotoninergic projections to different regions of the cat cerebellar cortex. J Comp Neurol (1991) 0.79
Worldwide on-road vehicle exhaust emissions study by remote sensing. Environ Sci Technol (1995) 0.79
The distribution of corticotropin-releasing factor (CRF), CRF binding sites and CRF1 receptor mRNA in the mouse cerebellum. Prog Brain Res (1997) 0.79
Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors. Med J Aust (1992) 0.79
Identification of the cellular subpopulations infiltrating rejecting cadaver renal allografts. Preponderance of the T4 subset of T cells. Transplantation (1984) 0.78
Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia. Dis Nerv Syst (1977) 0.78
Presynaptic localization of a truncated isoform of the type 2 corticotropin releasing factor receptor in the cerebellum. Neuroscience (2006) 0.78
Portal capillary destruction in liver allograft rejection. Transplant Proc (1992) 0.78
Atherosclerosis of the liver allograft. J Hepatol (1997) 0.78
Antigen-specific B cell tumors of mice. Crit Rev Immunol (1986) 0.78
Fine structural analysis of calcitonin gene-related peptide in the mouse inferior olivary complex. J Neurocytol (1999) 0.78